OpenLB
Open Library of Bioscience
Advanced Search

Journal

Publication Year

1 year 3 years 5 years 10 years
2021 - 2032
202120222023
202420252026
202720282029
203020312032
2021 - 2032
202120222023
202420252026
202720282029
203020312032

Publication Type

Associated Data

Found 36,395 results

Filters: PrEP

Intention and preference for long-acting injectable PrEP among MSM in the Netherlands: a diffusion of innovation approach
Wang, H.; Zimmermann, H. M. L.; van de Vijver, D.; Jonas, K. J.
medrxiv. 2022-11-11. Preprint
Source:medrxiv
PPRID: 10.1101/2022.11.11.22282218v1 doi:NA
Understanding, Contextualizing, and Addressing PrEP Stigma to Enhance PrEP Implementation.
Sarah K Calabrese
Curr HIV/AIDS Rep. 12, 2020.17(6):579-588 Print-Electronic
Source:PubMed
PMID: 32965576 doi:10.1007/s11904-020-00533-y
Influence of serosorting and intervention-mediated changes in serosorting on the population-level HIV transmission impact of pre-exposure prophylaxis among men who have sex with men: a mathematical modelling study
Wang, L.; Moqueet, N.; Simkin, A.; Knight, J.; Ma, H.; Lachowsky, N. J.; Armstrong, H. L.; Tan, D. H. S.; Burchell, A. N.; Hart, T. A.; Moore, D. M.; Adam, B. D.; MacFadden, D. R.; Baral, S.; Mishra, S.
medrxiv. 2020-02-26. Preprint
Source:medrxiv
PPRID: 10.1101/2020.02.26.20025700v1 doi:10.1097/qad.0000000000002826
Expanded Choices with Greater HIV Prevention Benefits: A Mathematical Model of Long-Acting Injectable and Daily-Oral Pre-Exposure Prophylaxis
Maloney, K. M.; Driggers, R. A.; Sarkar, S.; Anderson, E.; Malik, A.; Jenness, S. M.
medrxiv. 2019-11-22. Preprint
Source:medrxiv
PPRID: 10.1101/19012443v1 doi:10.1093/infdis/jiaa552
Projected Impact of Concurrently Available Long-Acting Injectable and Daily-Oral HIV Pre-Exposure Prophylaxis: A Mathematical Model
Maloney, K. M.; Le Guillou, A.; Driggers, R. A.; Sarkar, S.; Anderson, E.; Malik, A.; Jenness, S. M.
medrxiv. 2020-08-12. Preprint
Source:medrxiv
PPRID: 10.1101/19012443v3 doi:10.1093/infdis/jiaa552
Association Between HIV PrEP Indications and Use in a National Sexual Network Study of Men Who Have Sex with Men
Weiss, K. M.; Prasad, P.; Sanchez, T.; Goodreau, S. M.; Jenness, S. M.
medrxiv. 2021-03-05. Preprint
Source:medrxiv
PPRID: 10.1101/2021.03.03.21252823v1 doi:NA
Projected Impact of Concurrently Available Long-Acting Injectable and Daily-Oral HIV Pre-Exposure Prophylaxis: A Mathematical Model
Maloney, K. M.; Le Guillou, A.; Driggers, R. A.; Sarkar, S.; Anderson, E.; Malik, A.; Jenness, S. M.
medrxiv. 2020-06-06. Preprint
Source:medrxiv
PPRID: 10.1101/19012443v2 doi:10.1093/infdis/jiaa552
Predicting and influencing PrEP use: the role of motivational and attitudinal factors.
S J Savoie, C Leonhard, M Smith, M Drake
AIDS Care. 09, 2023.35(9):1354-1364 Print-Electronic
Source:PubMed
PMID: 36781301 doi:10.1080/09540121.2023.2176427
Prescribing pre-exposure prophylaxis (PrEP) for HIV prevention: A cross-sectional survey of General Practitioners in Australia
Wu, J.; Fairley, C. K.; Grace, D.; Bavinton, B. R.; Fraser, D.; Chan, C.; Chow, E. P. F.; Ong, J. J.
medrxiv. 2024-01-25. Preprint
Source:medrxiv
PPRID: 10.1101/2024.01.24.24301757v1 doi:NA
Are PrEP services in France reaching all those exposed to HIV who want to take PrEP? MSM respondents who are eligible but not using PrEP (EMIS 2017).
Margot Annequin, Virginie Villes, Rosemary M Delabre, Tristan Alain, Stéphane Morel, David Michels, Axel Jeremias Schmidt, Annie Velter, Daniela Rojas Castro
AIDS Care. 05, 2020.32(sup2):47-56 Print-Electronic
Source:PubMed
PMID: 32189518 doi:10.1080/09540121.2020.1739219
0